Myofasical pain
Conditions
Interventions
TPI+ usual care group: For the TPI treatment, 1 mL of 1% lidocaine was injected into each trigger point (maximum 2 sites) using a 26G, 13 mm needle on day 1.
Usual care group: For the Usual care, t
Sponsors
Hasuo Hideaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Non-curable solid cancers 2) The reference diagnostic criteria of the MRS of Rivers are met 3) Average NRS of pain 24 hours before registration is greater than 4 or 4 4) Hospitalization at the registration within 14 days before registration 5) Age at registration is over 20 years old 6) Sustained main organ function 7) Witten informed consent
Exclusion criteria
Exclusion criteria: 1) There are cancer lesions in the same site as MPS by imaging examination within 4 weeks before registration 2) Change of regular analgesic drugs within 24 hours before registration 3) Psychiatric diseases or conditions that made communication difficult, such as cognitive impairment or disturbance of consciousness 4) Allergy to local anesthetics of the amide type 5) Pregnant and nursing 6) Patient who is considered ineligible for enrolling the study by a principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients whose average NRS score for the past 24 hours of MPS decreased by 50% or more from before the intervention to 72 hours after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Personalized pain goal achievement, change rate of pain pressure threshold, patient satisfaction, adverse events | — |
Contacts
Public ContactHideaki Hasuo
Kansai Medical University University
Outcome results
None listed